BioSpace News Archive

Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at two investor conferences in September and October 2019.

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest demand management solution for a medical device company.

Parks Associates will examine the market for IoT health solutions and current trends in the connected health market during “Connected Health: Serving Consumers at Home,” the pre-show workshop for Connected Health Summit on August 27.

Philip C. Brittain, DO with Vibrant Life is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).

The world largest online healthcare platform, Ping An Good Doctor (01833.HK), has seen its share price rise sharply recently, closing at HK $48.35 on 23 August, up 6.73%.

Jennifer Trinidad, with Body Renaissance is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).

Nevro Corp. announced the Company will be participating in the Morgan Stanley 17th Annual Healthcare Conference in New York City.

IM HealthScience®, innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among a representative and projectable sample of U.S. gastroenterologists, revealed FDgard® as the #1-recommended product for Functional Dyspepsia (FD or meal-triggered indigestioni)

The global antimicrobial susceptibility testing market size is poised to reach USD 832.14 million by 2023, according to a new report by Technavio, progressing at a CAGR of 5% during the forecast period.

Charles Lively MD is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).